Optimi Health Corp (OPTI)

Optimi Health Corp Company Information

Name	Optimi Health Corp
Symbol	OPTI
Sector	Consumer Defensive
Industry	Farm Products
Website	https://optimihealth.ca
Twitter	N/A
Headquarters	201-1448 Commercial Drive Vancouver BC V5L 3X9
Phone	778 930-1321

Optimi health is one of the major companies in the health care sector, focusing on biotechnology and pharmaceuticals. 

The brand is involved in the manufacturing and distribution of mushroom-based products, including formulation capsules, recreational, psilocybin, and mushroom extracts.

Optimi is based in Vancouver, Canada, where it is currently building two state-of-the-art facilities that will be utilized to create top-quality mushroom brands that target the health and wellness markets. The company will take charge of all the processes, from cultivation to consumer sales. 

The brand was granted a research exemption under the Health Canada Food and Drugs Regulations (FDR) to conduct research studies on the science of mushrooms comprehensively. This was achieved through Optimi Labs Inc, one of its wholly owned subsidiaries. The lab will be primarily focusing on psilocybin and psilocin. 

Optimi has applied for a license that legally allows it to conduct laboratory analysis and the research and development of psilocybin and psilocin. The license will also cover the possession, distribution and sale of the psychedelics’ formulations. 

Optimi strives to become a renowned leader in the production and distribution of psilocybin and a wide range of nutraceutical products, with strict adherence to the governing laws. 

The line of mushroom-based products aims at optimizing and transforming human development by focusing on their mental, physical, and spiritual well-being.

Through utilizing its knowledgeable and experienced advisory team and the in-house expert researchers, Optimi seeks to dominate the supplements and nutraceutical scene along with any promising future opportunities in the pharmaceuticals world. Ultimately, the brand’s goal is to transform from a regional business to a global leader. 

Optimi Health’s products

Optimi Health uniquely designs its products to promote optimum human performance. They include a wide range of proprietary fungi-based products made using mushroom genuses such as Cordyceps, Lions Mane, Turkey Tail, Chaga, and Reishi. 

The brand is involved in every aspect of the business, from cultivation, harvesting, extraction, production, sales, to distribution. 

Through this, the company avoids intermediaries and inspects every stage of its operation to ensure its products’ purity throughout the entire process. 

Also, most companies either focus on functional mushroom cultivation or the health food industry, but Optima is involved in both, which gives it an advantage over its competitors. 

In the second quarter of 2021, Optima plans to start selling and distributing its products via its e-commerce website.

Optimi Labs Inc

Through its wholly owned Subsidiary (Optimi Labs Inc), Optimi Health seeks to create proprietary formulations, contribute to intellectual property development, and conduct studies that aim to facilitate the development of mental and physical performance.

The brand plans to achieve this by forming strategic partnerships with scientific experts, renowned professional researchers, and academic institutions.

Optimi labs main functions

1. Improving the efficacy of the extraction process
2. Creation of novel human delivery systems 
3. Product development
4. Exploration of synthetic and non-synthetic compounds

Optimi Health Farms

In 2020, the company commenced the construction of its two facilities based in Princeton, BC. The facilities are adjacent to each other, and each coves approximately 10,000 square feet. 

At the beginning of 2021, Optimi began phase 2 of the construction, which involved installing state-of-the-art processing equipment and machinery and setting up an inhouse analytics laboratory. 

The construction is expected to reach completion by the end of the 2021 second quarter, while planting is projected to commence in the 3rd quarter. 

Optimi intends to utilize the facilities to produce a variety of highly functional products made from natural psilocybin and its derivatives.